瑞迈特收盘上涨1.81%，滚动市盈率42.42倍，总市值75.26亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Ruimait Medical Technology Co., Ltd., particularly in the respiratory health medical device sector [1][2] - As of July 16, Ruimait's stock closed at 83.99 yuan, with a 1.81% increase, resulting in a rolling PE ratio of 42.42 times and a total market capitalization of 7.526 billion yuan [1] - The average PE ratio for the medical device industry is 51.87 times, with a median of 37.48 times, placing Ruimait at the 81st position in the industry ranking [1][2] Group 2 - For the first quarter of 2025, Ruimait reported an operating revenue of 265 million yuan, reflecting a year-on-year increase of 38.11%, and a net profit of 71.9314 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] - The company specializes in manufacturing medical devices and consumables in the respiratory health field, with key products including various types of sleep breathing machines and monitoring devices [1] - Ruimait holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, along with 202 international patents across various countries [1]